Aesthetics

BoNT/E represents a novel approach in the world of neurotoxins, characterized by its rapid onset of action.

Pharmacists play a role in advising patients with hair loss about self-management and proper application of over the counter products.

Cheryl Burgess, MD, will share pearls on counseling patients on appropriate cosmetic procedures for their skin type, safety measures, and strategies to achieve desired outcomes.

Dermatology Times Editor in Chief Zoe Diana Draelos, MD, delves into the topic of hair health, including pearls and best practices for preventing hair breakage in patients.

Greg Pierce of Synchrony discusses CareCredit's Path to Care study and its findings related to cost and finance considerations for cosmetic dermatology patients.

Brauer’s textbook can be purchased through Amazon and Barnes & Noble.

Sachin Shridharani, MD, discusses the results of a recent Allergan Aesthetics study exploring the efficacy of onabotulinumtoxinA in treating platysma prominence.

A patient’s journey toward weight loss for overall better health involves multifaceted considerations that extend beyond the numbers on a scale when it comes to sagging or excess skin.

Jeffrey Yager, MD, discusses the new SY Aesthetics campus that will integrate traditional and Chinese healing.

Multiple microinjections significantly improved signs of aging up to 12 weeks after initial injection.

In this week’s Pointers With Portela, the 208SkinDoc discusses 5 key takeaways about Ozempic, including adverse effects and hidden risks.

With a wide range of aesthetic options available, clinicians can create a personalized approach to addressing age-related changes around the eye to give patients the natural-looking results they desire.

Martin presented clinical pearls regarding business management and facial balancing in Dallas, Texas.

In this month's Cosmetic Conundrums column, Zoe Diana Draelos, MD, describes peptides and their use in skin care.

Bempikibart offers a new approach to treating the disease by blocking signaling pathways.

Treatment groups showed faster healing and lower rates of erythema than control groups.

After 17 months, patients showed no signs of remission.

Researchers compared the efficacy of the 2 modalities and found that they were equal in safety, efficacy, and tolerability.

Steven Dayan, MD, FACS, first author behind a recent study involving high rates of patient satisfaction following treatment with botulinum toxin, discusses the importance of placing patient satisfaction at the forefront of cosmetic dermatology.

This Alopecia Awareness Month, we want to know your thoughts on necessary action points to improve alopecia awareness. Click here to answer this week's poll.

Topical minoxidil combined with oral spironolactone significantly improved hair density.

BTA treatment was both safe and effective in male and female patients, indicating its potential as a therapeutic strategy in treating Egyptian patients with AGA.

Researchers found no statistically significant difference between injection techniques.

After 4 weeks of daily use, 92% of participants showed an improvement in skin hydration.